One-third of high-grade serous ovarian, peritoneal and fallopian tube carcinomas (HGSC) have low percentage of neoplastic nuclei (PNN < 70%).
Higher PNN is associated with suboptimal cytoreduction and lower PNN is associated with inherited BRCA2 mutations.
Molecular analyses of HGSC selected for high PNN exclude a significant fraction of patients.